FDA Clears Smiths Medical’s Wireless Ambulatory Infusion Pump

Smiths Medical, a global medical device manufacturer, announced it has received FDA 510(k) clearance on the CADD-Solis ambulatory infusion pump with wireless communication. The new system helps hospitals increase efficiencies, reduce costs and improve patient outcomes.
 
The CADD-Solis ambulatory infusion pump can now communicate wirelessly to and from PharmGuard Server software. This allows clinicians to:
 

• Deploy software updates and drug libraries to all pumps simultaneously
• Remotely manage pump performance and monitor drug dosing
• Track pump location to the last known wireless access point
• Download infusion data reports to enable better therapy decisions for patients
• Enable data integration to the patient records to improve documentation accuracy and reduce time for patient-charting to the Electronic Medical Records (EMR)

 
The CADD-Solis pump combines the mobility advantages of an ambulatory pump and the efficiency of a single infusion system to deliver Intravenous Patient-Controlled Analgesia (IV PCA), epidurals and peripheral nerve blocks, in addition to other indications for use, including the subarachnoid space, into an intra-operative site, intra-arterial, and subcutaneous.
 
Successfully launched last year in Canada, Australia, New Zealand, Ireland and the United Kingdom, several hospitals have already implemented the CADD-Solis pump with wireless communication. The latest version is now available in the United States.